Chemokine Receptor-Targeted Therapies: Special Case for CCR8. (2022)
Attributed to:
The role of CCR8 in cutaneous vaccination
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers14030511
PubMed Identifier: 35158783
Publication URI: http://europepmc.org/abstract/MED/35158783
Type: Journal Article/Review
Volume: 14
Parent Publication: Cancers
Issue: 3
ISSN: 2072-6694